BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.1495
-0.0005 (-0.33%)
At close: Apr 2, 2026
BioLargo Revenue
In the year 2025, BioLargo had annual revenue of $7.77M, down -56.32%. BioLargo had revenue of $617.00K in the quarter ending December 31, 2025, a decrease of -83.13%.
Revenue
7.77M
Revenue Growth
-56.32%
P/S Ratio
6.14
Revenue / Employee
172.56K
Employees
46
Market Cap
47.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.77M | -10.01M | -56.32% |
| Dec 31, 2024 | 17.78M | 5.55M | 45.37% |
| Dec 31, 2023 | 12.23M | 6.35M | 107.85% |
| Dec 31, 2022 | 5.88M | 3.35M | 132.48% |
| Dec 31, 2021 | 2.53M | 99.00K | 4.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cardinal Ethanol, LLC | 350.34M |
| NuEarth | 15.34M |
| Vulcan International | 5.35M |
| Lithium & Boron Technology | 2.47M |
| Reflectkote | 2.06M |
| American Green Group | 688.17K |
| Angstrom Technologies | 642.35K |
| Energy and Environmental Services | 314.71K |
BioLargo News
- 4 days ago - BioLargo CEO Dennis Calvert to Present Global Environmental Leadership Award to Robert Bilott at Nassau County PFAS Forum - Accesswire
- 4 weeks ago - BioLargo Reports Annual 2025 Operating and Financial Results - Accesswire
- 4 weeks ago - BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern Time - Accesswire
- 6 weeks ago - BioLargo Subsidiary Clyra Medical Highlights Key Opinion Leader Presentation of Exceptional ViaCLYR(TM) Clinical Results at Leading Wound Care Symposium - Accesswire
- 7 weeks ago - BioLargo Subsidiary Clyra Medical Technologies Secures First Stocking Order with Advanced Solution for ViaCLYR(TM) Wound Irrigation Solution - Accesswire
- 2 months ago - BioLargo Installs AEC PFAS Treatment System at Lake Stockholm, New Jersey - Accesswire
- 2 months ago - BioLargo to Present at Sidoti's Micro-Cap Virtual Conference on Thursday January 22nd at 1pm EST - Accesswire
- 3 months ago - BioLargo Reflects on 2025 Progress and Positions for the Next Phase of Global Infrastructure, Environmental, and Medical Innovation - Accesswire